Table 3.
Results of prediction based on a combination of Helicobacter pylori antibody and serum pepsinogen screening
| Ohata et al[38] | Watabe et al[40] | Mizuno et al[39] | |
| Basic characteristics | |||
| Year published | 2004 | 2005 | 2009 |
| Location | Wakayama | Chiba | Kyoto |
| Total number | 4655 | 6983 | 2859 |
| Men/Women | 4655/0 | 3320/2260 | 1011/1848 |
| Age | 48.3 (average) | 48.9 (average) | ≥ 35 |
| Follow-up (yr) | 7.7 (average) | 4.7 (average) | 10 (maximum) |
| HP positive rate (%) | 78.6 | 46.1 | 75 |
| PG positive rate (%) | 28.9 | 21.8 | 39.2 |
| Number of detected cancer | 45 | 43 | 61 |
| Incidence of gastric cancer (/1000) | 9.67 | 6.16 | 21.3 |
| HP-/PG- | |||
| Total number | 967 | 3324 | 647 |
| Number of detected cancer | 0 | 7 | 2 |
| Incidence of gastric cancer (/1000) | - | 2.11 | 3.09 |
| HP+/PG- | |||
| Total number | 2341 | 2134 | 1094 |
| Number of detected cancer | 19 | 6 | 15 |
| Incidence of gastric cancer (/1000) | 8.12 | 2.81 | 13.71 |
| HP+/PG+ | |||
| Total number | 1316 | 1082 | 1054 |
| Number of detected cancer | 24 | 18 | 41 |
| Incidence of gastric cancer (/1000) | 18.24 | 16.64 | 38.9 |
| HP-/PG+ | |||
| Total number | 31 | 443 | 69 |
| Number of detected cancer | 2 | 12 | 3 |
| Incidence of gastric cancer (/1000) | 64.52 | 27.09 | 43.48 |
HP: Helicobacter pylori antibody; PG: Serum pepsinogen.